Mitrovic M, Suvajdzic N, Bogdanovic A, et al.International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6:a new predictor of hemorrhagic early death in acute promyelocytic leukemia[J].Med Oncol, 2013, 30:478.

Park JH, Qiao B, Panageas KS, et al.Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid[J].Blood, 2011, 118:1248-1254.

Paulson K, Serebrin A, Lambert P, et al.Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres:apan-Canadian epidemiological study[J].Br J Haematol, 2014, 166:660-666.

Chang H, Kuo MC, Shih LY, et al.Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia[J].Eur J Haematol, 2012, 88:321-328.

Yan J, Wang K, Dong L, et al.PML/RARalpha fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA association[J].Proc Natl Acad Sci U S A, 2010, 107:3716-3721.

Ma G, Liu F, Lv L, et al.Increased promyelocytic-derived micro particles:a novel potential factor for coagulopathy in acute promyelocytic leukemia[J].Ann Hematol, 2013, 92:645-652.

Madoiwa S, Tanaka H, Nagahama Y, et al.Degradation of cross-linked fibrin by leukocyte elastase as alternative pathway for plasmin-mediated fibrinolysis in sepsis-induced disseminated intravascular coagulation[J].Thromb Res, 2011, 127:349-355.

Liu Y, Wang Z, Jiang M, et al.The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia[J].Leuk Res, 2011, 35:879-884.

Papadakis E, Hoffman R, Brenner B.Thrombohemorrhagic complications of myeloproliferative disorders[J].Blood Rev, 2010, 24:227-232.

Franchini M, Frattini F, Crestani S, et al.Bleeding complications in patients with hematologic malignancies[J].Semin Thromb Hemost, 2013, 39:94-100.

Lee HJ, Park HJ, Kim HW, et al.Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation[J].Blood Res, 2013, 48:250-253.

梅恒, 胡豫.《中国弥散性血管内凝血诊断积分系统》解读[J].临床血液学杂志, 2017, 30 (7):495-498.

Wu Y, Luo L, Niu T, et al.Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients:A multicenter prospective study[J].Sci Rep, 2017, 7:9057.

Stein E, McMahon B, Kwaan H, et al.The coagulopathy of acute promyelocytic leukaemia revisited[J].Best Pract Res Clin Haematol, 2009, 22:153-163.

Altman JK, Rademaker A, Cull E, et al.Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death[J].Leuk Res, 2013, 37:1004-1009.

Levi M, Toh CH, Thachil J, et al.Guidelines for the diagnosis and management of disseminated intravascular coagulation[J].Br J Haematol, 2009, 145:24-33.

Squizzato A, Hunt BJ, Kinasewitz GT, et al.Supportive management strategies for disseminated intravascular coagulation.An international consensus[J].Thromb Haemost, 2016, 115:896-904.

Wada H, Japanese Society of Thrombosis Hemostasis/DIC subcommittee, Okamoto K, et al.Addition of recommendations for the use of recombinant human thrombomodulin to the"Expert consensus for the treatment of disseminated intravascular coagulation in Japan"[J].Thromb Res, 2014, 134:924-925.

Franchini M, Di Minno MN, Coppola A.Disseminated intravascular coagulation in hematologic malignancies[J].Semin Thromb Hemost, 2010, 36:388-403.

Martí-Carvajal AJ, Anand V, SolàI.Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia[J].Cochrane Database Syst Rev, 2015, 24:CD008562.

Ker K, Edwards P, Perel P, et al.Effect of tranexamic acid on surgical bleeding:systematic review and cumulative meta-analysis[J].BMJ, 2012, 344:e3054.